Literature DB >> 6034840

Diazoxide blood levels in man.

S Symchowicz, L Winston, J Black, M Smith, B Calesnick, I I Tabachnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6034840     DOI： 10.1002/jps.2600560730

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  11 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Haemolysis associated with diazoxide, used for the control of hypertension.

Authors:  R A Best; H M Clink
Journal:  Postgrad Med J       Date:  1975-06       Impact factor: 2.401

3.  Population Pharmacokinetics of Diazoxide in Children with Hyperinsulinemic Hypoglycemia.

Authors:  Rika Kizu; Kazuko Nishimura; Reiko Sato; Kenjiro Kosaki; Toshiaki Tanaka; Yusuke Tanigawara; Tomonobu Hasegawa
Journal:  Horm Res Paediatr       Date:  2017-07-14       Impact factor: 2.852

4.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

5.  Effects of fetal exposure to diazoxide in man.

Authors:  R D Milner; S K Chouksey
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

Review 6.  Diazoxide: a review of its pharmacological properties and therapeutic use in hypertensive crises.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

7.  A comparison of the binding of drugs to adult and cord plasma.

Authors:  A W Pruitt; P G Dayton
Journal:  Eur J Clin Pharmacol       Date:  1971-12       Impact factor: 2.953

Review 8.  Pharmacokinetics and response to diazoxide in renal failure.

Authors:  R M Pearson
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

9.  Renal function, protein binding and pharmacological response to diazoxide.

Authors:  R M Pearson; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

10.  Diazoxide in treatment of primary pulmonary hypertension.

Authors:  S W Wang; J E Pohl; D J Rowlands; E G Wade
Journal:  Br Heart J       Date:  1978-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.